Korro Bio Balance Sheet Health
Financial Health criteria checks 6/6
Korro Bio has a total shareholder equity of $198.1M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $249.6M and $51.5M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$157.43m |
Equity | US$198.08m |
Total liabilities | US$51.51m |
Total assets | US$249.59m |
Financial Position Analysis
Short Term Liabilities: KRRO's short term assets ($163.6M) exceed its short term liabilities ($12.3M).
Long Term Liabilities: KRRO's short term assets ($163.6M) exceed its long term liabilities ($39.2M).
Debt to Equity History and Analysis
Debt Level: KRRO is debt free.
Reducing Debt: KRRO has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: KRRO has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: KRRO has sufficient cash runway for 1.7 years if free cash flow continues to reduce at historical rates of 27% each year.